Home/Immorta Bio/Thomas Ichim
TI

Thomas Ichim

Executive (likely CSO/Co-founder)

Immorta Bio

Immorta Bio Pipeline

DrugIndicationPhase
SenoVax™ PlatformSenescence-associated diseases / AgingPre-clinical
StemCell Revivify™ PlatformTissue regeneration / AgingPre-clinical